2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives,...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S121000

Reexamination Certificate

active

07915284

ABSTRACT:
The present invention is related to a compound of formula (I)wherein R1, R2, R3and R4are as defined herein, or an addition salt of an acid thereof, the pharmaceutical composition and preparation thereof, and the therapeutic use thereof in the treatment or the prevention of diseases involving Nurr-1 nuclear receptors, also known as NR4A2, NOT, TINUR, RNR-1 and HZF3.

REFERENCES:
patent: 2001035664 (2001-02-01), None
patent: WO 01/74813 (2001-10-01), None
patent: WO 2004/026867 (2004-04-01), None
patent: WO 2004/072050 (2004-08-01), None
patent: WO 2005/086808 (2005-09-01), None
Enguehard, C., et. al., (Hetero)Arylation of 6-Halogenoimidazo [1,2-a]Pyridines Differently Substituted at C(2): Influence of the 2-Substituent on the Suzuki Cross-Coupling Reaction, Helvetica Chimica Acta, vol. 84, (2001).
Wang, Z., et. al., Structute and Function of Nurr1 Identifies a Class of Ligand-Independent Nuclear Receptors, Nature vol. 423, 555-560, (2003).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives,... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2735803

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.